Dr. Peter J. Park, M.D.
Interventional Radiology (Vascular & Interventional Radiology Physician)
- Medicare participating
At a glance
- Medical school
- Johns Hopkins University School of Medicine (2014)
- Years since graduation
- 12
- In the NPI registry since
- 2013
- Medicare patients seen, 2024
- 121
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2014Medical school: Johns Hopkins University School of Medicine
- 2013Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Vascular & Interventional Radiology Physician primary
GA license 007281 -
Diagnostic Radiology Physician
GA license 007281
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Emory University Hospital Atlanta, GA
- Emory University Hospital Midtown Atlanta, GA
- Emory Decatur Hospital Decatur, GA
Medical groups
- The Emory Clinic Inc (3,568 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 121
- Services billed
- 384
- Patients’ average age
- 69
| Service | Times | Patients |
|---|---|---|
| Ultrasonic guidance for blood vessel access | 71 | 65 |
| Fluoroscopic guidance for insertion or removal of central vein access device | 56 | 54 |
| Review by radiologist of additional artery image | 44 | 15 |
| Insertion of tunneled central venous tube for infusion (5 years or older) | 40 | 39 |
| Review by radiologist of abdominal artery image | 29 | 17 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | 24 | 17 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 21 | 21 |
| Occlusion of growths or obstructed vessels with review by radiologist | 14 | 13 |
| Removal of tunneled central venous tube | 13 | 13 |
| Review by radiologist of ct guidance for needle placement | 13 | 13 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Ciprofloxacin Hcl Other prescribers in Atlanta, GA | 58 |
| Ondansetron Odt (ondansetron) Other prescribers in Atlanta, GA | 53 |
| Oxycodone Hcl Other prescribers in Atlanta, GA | 52 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 8 companies reported 42 payments worth $6,084 in total to this clinician.
| Boston Scientific Corporation | $2,138 |
|---|---|
| Penumbra, Inc. | $1,899 |
| Terumo Medical Corporation | $1,664 |
| Argon Medical Devices, Inc. | $237 |
| Imperative Care, Inc | $68.96 |
| Siemens Medical Solutions USA, Inc. | $36.12 |
| Trisalus Life Sciences, Inc. | $24.16 |
| Balt USA, LLC | $16.98 |
| Travel and Lodging | $3,320 |
|---|---|
| Food and Beverage | $2,764 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Terumo Medical Corporation Feb 20, 2025 | Travel and Lodging AZUR CX DETACHABLE · VASCULAR EMBOLIZATION · travel to ALISO VIEJO, CA · in-kind | $855 |
| Penumbra, Inc. Feb 27, 2025 | Travel and Lodging Indigo System · Peripheral Intervention · travel to Alameda, CA | $774 |
| Penumbra, Inc. Feb 27, 2025 | Travel and Lodging Indigo System · Peripheral Intervention · travel to Alameda, CA | $469 |
| Boston Scientific Corporation Nov 15, 2025 | Travel and Lodging TheraSphere Y90 Glass Microspheres 10 GBq · TheraSphere_PI · travel to Chicago, IL · in-kind | $428 |
| Boston Scientific Corporation Nov 13, 2025 | Travel and Lodging TheraSphere Y90 Glass Microspheres 10 GBq · TheraSphere_PI · travel to Chicago, IL · in-kind | $297 |
| Terumo Medical Corporation Apr 7, 2025 | Travel and Lodging AZUR CX DETACHABLE · VASCULAR EMBOLIZATION · travel to ALISO VIEJO, CA · in-kind | $228 |
| Terumo Medical Corporation Apr 7, 2025 | Travel and Lodging AZUR CX DETACHABLE · VASCULAR EMBOLIZATION · travel to ALISO VIEJO, CA · in-kind | $151 |
| Terumo Medical Corporation Apr 8, 2025 | Travel and Lodging AZUR CX DETACHABLE · VASCULAR EMBOLIZATION · travel to ALISO VIEJO, CA · in-kind | $75.60 |
| Penumbra, Inc. Feb 27, 2025 | Travel and Lodging Indigo System · Peripheral Intervention · travel to Alameda, CA | $42.04 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $24,526 in research payments for these studies, mostly to the institutions running them.
- Obsidio™ Conformable Embolic Registry
Boston Scientific Corporation · Completed · NCT06170619
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.